The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shanmugam Muthusamy since 2022.
This trader's CIK number is 1870913.
At the time of last reporting, Shanmugam Muthusamy was the HEAD OF R&D, COO-NOVITIUM OPS of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP).
Also see all insider trading activities at Ani Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ANIP | 0 | $0 | 200,700 | $17,914,320 | 0 | $0 |
| 2024 | ANIP | 0 | $0 | 300,000 | $18,725,654 | 0 | $0 |
| 2023 | ANIP | 0 | $0 | 389,190 | $22,064,498 | 0 | $0 |
| 2022 | ANIP | 10,000 | $276,500 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | ANIP | Sale | 52,988 | 90.44 | 4,792,234 |
| 2025-08-20 | ANIP | Sale | 47,012 | 90.27 | 4,243,773 |
| 2025-08-14 | ANIP | Sale | 47,010 | 89.48 | 4,206,454 |
| 2025-08-15 | ANIP | Sale | 52,990 | 87.15 | 4,618,078 |
| 2025-05-09 | ANIP | Sale | 700 | 76.83 | 53,781 |
| 2024-07-18 | ANIP | Sale | 2,743 | 62.00 | 170,066 |
| 2024-07-17 | ANIP | Sale | 14,257 | 63.16 | 900,472 |
| 2024-07-16 | ANIP | Sale | 22,000 | 64.27 | 1,413,940 |
| 2024-07-15 | ANIP | Sale | 11,000 | 63.38 | 697,180 |
| 2024-06-21 | ANIP | Sale | 20,000 | 58.90 | 1,178,000 |
| 2024-06-17 | ANIP | Sale | 7,946 | 61.41 | 487,963 |
| 2024-06-18 | ANIP | Sale | 10,607 | 60.76 | 644,481 |
| 2024-06-20 | ANIP | Sale | 11,447 | 59.86 | 685,217 |
| 2024-05-20 | ANIP | Sale | 12,855 | 61.81 | 794,567 |
| 2024-05-15 | ANIP | Sale | 14,850 | 65.86 | 978,021 |
| 2024-05-17 | ANIP | Sale | 5,836 | 62.09 | 362,357 |
| 2024-05-16 | ANIP | Sale | 16,459 | 63.84 | 1,050,742 |
| 2024-04-18 | ANIP | Sale | 10,423 | 64.98 | 677,286 |
| 2024-04-19 | ANIP | Sale | 16,809 | 65.17 | 1,095,442 |
| 2024-04-17 | ANIP | Sale | 9,520 | 65.40 | 622,608 |
| 2024-04-15 | ANIP | Sale | 7,414 | 66.33 | 491,770 |
| 2024-04-16 | ANIP | Sale | 5,834 | 66.20 | 386,210 |
| 2024-03-08 | ANIP | Sale | 10,000 | 67.17 | 671,700 |
| 2024-03-07 | ANIP | Sale | 15,085 | 66.35 | 1,000,889 |
| 2024-03-06 | ANIP | Sale | 14,822 | 65.47 | 970,396 |
| 2024-03-05 | ANIP | Sale | 10,093 | 65.35 | 659,577 |
| 2024-01-19 | ANIP | Sale | 4,524 | 55.57 | 251,398 |
| 2024-01-22 | ANIP | Sale | 5,692 | 55.95 | 318,467 |
| 2024-01-23 | ANIP | Sale | 15,000 | 56.44 | 846,600 |
| 2024-01-16 | ANIP | Sale | 5,000 | 55.63 | 278,150 |
| 2024-01-17 | ANIP | Sale | 10,000 | 55.11 | 551,100 |
| 2024-01-18 | ANIP | Sale | 9,784 | 55.30 | 541,055 |
| 2023-12-15 | ANIP | Sale | 11,974 | 52.44 | 627,916 |
| 2023-12-18 | ANIP | Sale | 13,026 | 52.44 | 683,083 |
| 2023-12-19 | ANIP | Sale | 25,000 | 52.65 | 1,316,250 |
| 2023-11-17 | ANIP | Sale | 13,000 | 51.00 | 663,000 |
| 2023-11-16 | ANIP | Sale | 6,448 | 51.66 | 333,103 |
| 2023-11-15 | ANIP | Sale | 7,647 | 53.64 | 410,185 |
| 2023-11-14 | ANIP | Sale | 22,095 | 53.17 | 1,174,791 |
| 2023-10-17 | ANIP | Sale | 8,758 | 58.53 | 512,605 |
| 2023-10-18 | ANIP | Sale | 6,242 | 57.78 | 360,662 |
| 2023-10-19 | ANIP | Sale | 10,000 | 57.06 | 570,600 |
| 2023-10-13 | ANIP | Sale | 11,937 | 57.58 | 687,332 |
| 2023-10-16 | ANIP | Sale | 13,063 | 58.31 | 761,703 |
| 2023-09-19 | ANIP | Sale | 25,333 | 61.23 | 1,551,139 |
| 2023-09-18 | ANIP | Sale | 8,425 | 61.64 | 519,317 |
| 2023-09-15 | ANIP | Sale | 16,242 | 62.81 | 1,020,160 |
| 2023-08-28 | ANIP | Sale | 25,000 | 63.06 | 1,576,500 |
| 2023-08-29 | ANIP | Sale | 25,000 | 63.37 | 1,584,250 |
| 2023-08-14 | ANIP | Sale | 27,890 | 61.15 | 1,705,473 |
| 2023-08-15 | ANIP | Sale | 22,110 | 61.60 | 1,361,976 |
| 2023-07-21 | ANIP | Sale | 11,500 | 52.56 | 604,440 |
| 2023-07-20 | ANIP | Sale | 6,000 | 51.52 | 309,120 |
| 2023-07-19 | ANIP | Sale | 5,969 | 51.48 | 307,284 |
| 2023-07-17 | ANIP | Sale | 9,831 | 51.06 | 501,970 |
| 2023-07-18 | ANIP | Sale | 6,700 | 51.84 | 347,328 |
| 2023-07-14 | ANIP | Sale | 10,000 | 50.43 | 504,300 |
| 2023-06-20 | ANIP | Sale | 14,657 | 51.93 | 761,138 |
| 2023-06-21 | ANIP | Sale | 11,843 | 51.95 | 615,243 |
| 2023-06-22 | ANIP | Sale | 13,500 | 51.38 | 693,630 |
| 2022-03-17 | ANIP | Buy | 10,000 | 27.65 | 276,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS of Ani Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.